We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+19.29%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
AUM
$16.3B
AUM Growth
+$2.83B
Cap. Flow
-$1.17B
Cap. Flow %
-7.17%
Top 10 Hldgs %
36.28%
Holding
315
New
38
Increased
65
Reduced
120
Closed
39

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$135M
2
NFLX icon
Netflix
NFLX
+$114M
3
CDNS icon
Cadence Design Systems
CDNS
+$90.7M
4
TTD icon
Trade Desk
TTD
+$71.4M
5
AVGO icon
Broadcom
AVGO
+$68.3M

Sector Composition

Rank Sector Weight
1 Technology 38.21%
2 Healthcare 18.58%
3 Financials 14.62%
4 Industrials 12.42%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALNY icon
101
Alnylam Pharmaceuticals
ALNY
$33.5B
$35.4M 0.22%
185,000
-50,000
-21% -$8.52M
RLI icon
102
RLI Corp
RLI
$5.55B
$34.6M 0.21%
520,000
IMCR icon
103
Immunocore
IMCR
$1.68B
$34.2M 0.21%
501,300
+251,300
+101% +$13.1M
ICE icon
104
Intercontinental Exchange
ICE
$88.4B
$32.9M 0.2%
256,302
+41,417
+19% +$4.7M
PEN icon
105
Penumbra
PEN
$12.5B
$32.1M 0.2%
127,574
-631
-0.5% -$139K
IRON icon
106
Disc Medicine
IRON
$2.65B
$31.6M 0.19%
546,915
ADUS icon
107
Addus HomeCare
ADUS
$2.19B
$31.2M 0.19%
336,180
-2,961
-0.9% -$257K
ADI icon
108
Analog Devices
ADI
$175B
$30.7M 0.19%
154,430
+5,100
+3% +$911K
DXCM icon
109
DexCom
DXCM
$31.3B
$30.4M 0.19%
244,667
-690,837
-74% -$70.6M
DCPH
110
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$29.8M 0.18%
1,850,000
+100,000
+6% +$1.28M
PRA
111
DELISTED
ProAssurance
PRA
$29.8M 0.18%
2,162,500
CABA icon
112
Cabaletta Bio
CABA
$463M
$28.4M 0.17%
+1,250,000
New +$21M
RVNC
113
DELISTED
Revance Therapeutics, Inc.
RVNC
$27.9M 0.17%
3,169,239
-991,072
-24% -$8.12M
MRVL icon
114
Marvell Technology
MRVL
$197B
$25.5M 0.16%
422,200
-1,516,208
-78% -$81.9M
INTU icon
115
Intuit
INTU
$90.6B
$24.7M 0.15%
39,540
-17,459
-31% -$9.63M
ZBH icon
116
Zimmer Biomet
ZBH
$17.8B
$24.3M 0.15%
199,530
-929
-0.5% -$104K
SWAV
117
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$24.2M 0.15%
+126,908
New +$24M
WOLF icon
118
Wolfspeed
WOLF
$1.25B
$24.1M 0.15%
554,400
+129,200
+30% +$4.69M
PODD icon
119
Insulet
PODD
$9.15B
$24.1M 0.15%
110,971
+92,000
+485% +$15.8M
USFD icon
120
US Foods
USFD
$20.6B
$23.7M 0.15%
521,503
-78,349
-13% -$3.24M
ALC icon
121
Alcon
ALC
$32.7B
$23.4M 0.14%
340,473
-1,568
-0.5% -$116K
URI icon
122
United Rentals
URI
$61.6B
$23.4M 0.14%
40,761
-9,986
-20% -$4.71M
SPOT icon
123
Spotify
SPOT
$108B
$22.6M 0.14%
+120,519
New +$21M
ON icon
124
ON Semiconductor
ON
$27.9B
$22.4M 0.14%
268,100
-874,368
-77% -$68.7M
CGNX icon
125
Cognex
CGNX
$10.8B
$22M 0.13%
527,474
+385,986
+273% +$14.8M

Similar funds

Polar Capital Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, Polar Capital Holdings held 315 positions worth $16.3B, up 21% from $13.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Polar Capital Holdings withdrew a net $1.17B in Q4 2023, closing 39 positions and reducing 120 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in Netflix worth $127M.

  • Polar Capital Holdings's largest Q4 2023 buy was Netflix: 2,609,240 shares worth $127M.
  • Polar Capital Holdings added most to Micron Technology in Q4 2023, an estimated $135M increase.
  • Polar Capital Holdings's biggest Q4 2023 reduction was Microsoft, cutting an estimated $164M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q4 2023, selling an estimated $60.5M.
  • Polar Capital Holdings's ten largest holdings make up 36% of its $16.3B portfolio in Q4 2023.
  • Polar Capital Holdings opened 38 new positions and closed 39 in Q4 2023.
  • Polar Capital Holdings's portfolio value rose 21% quarter-over-quarter to $16.3B.

Based on Polar Capital Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.